Symbol="FREQ"
AssetType="Common Stock"
Name="Frequency Therapeutics Inc"
Description="Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on harnessing the body's innate biology to repair or reverse the damage caused by a variety of degenerative diseases. The company is headquartered in Woburn, Massachusetts."
CIK="1703647"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="19 PRESIDENTIAL WAY, SUITE 203, WOBURN, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="25380300"
EBITDA="-72045000"
PERatio="None"
PEGRatio="None"
BookValue="1.489"
DividendPerShare="0"
DividendYield="0"
EPS="-3.84"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.352"
ReturnOnEquityTTM="-0.937"
RevenueTTM="0"
GrossProfitTTM="-42015000"
DilutedEPSTTM="-3.84"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-1"
AnalystTargetPrice="4"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="7.5"
PriceToBookRatio="0.908"
EVToRevenue="0.0983"
EVToEBITDA="-0.235"
Beta="0.622"
num_52WeekHigh="5.59"
num_52WeekLow="0.326"
num_50DayMovingAverage="0.377"
num_200DayMovingAverage="1.53"
SharesOutstanding="35752000"
DividendDate="None"
ExDividendDate="None"
symbol="FREQ"
open="0.64"
high="0.74"
low="0.59"
price="0.62"
volume="8029416.00"
latest_trading_day="2023-07-17"
previous_close="0.71"
change="-0.09"
change_percent="-12.6638%"
aroon_positive_momentum_days="2"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="2"
Volume_recent_avg="1151677"
Change_recent_avg="0.01"
Delta_recent_avg="0.04"
Variance_recent_avg="0.02"
Change_ratio_recent_avg="-0.2"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="2"
Aroon_momentum_negative="98"
image_negative_thumbnail_id_1="487"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0118.jpeg"
image_negative_thumbnail_id_2="1129"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0162.jpeg"
image_neutral_thumbnail_id_1="584"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0015.jpeg"
image_neutral_thumbnail_id_2="542"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0057.jpeg"
image_positive_thumbnail_id_1="673"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0035.jpeg"
image_positive_thumbnail_id_2="705"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0003.jpeg"
image_professor_thumbnail_id_1="1204"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0038.jpeg"
image_professor_thumbnail_id_2="1184"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0018.jpeg"
